Merck Commits to Veeva Vault CRM
Veeva Systems (NYSE: VEEV) announced that Merck (NYSE: MRK) has committed to implementing Veeva Vault CRM to support their upcoming product launches across multiple therapeutic areas.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) announced that Merck (NYSE: MRK) has committed to implementing Veeva Vault CRM to support their upcoming product launches across multiple therapeutic areas. The partnership expansion highlights Merck's strategic decision to leverage Vault CRM for enhanced commercial execution.
Vault CRM, part of the Vault CRM Suite, offers deep applications for commercial execution across personal and digital channels, featuring advanced global capabilities to address region-specific business and compliance requirements. This technology adoption comes at a crucial time as Merck prepares for one of its most significant launch periods in company history.
Positive
- Strategic partnership expansion with major pharmaceutical company Merck
- Implementation supports Merck's significant upcoming product launch period
- Demonstrates market validation of Veeva's Vault CRM platform
Negative
- None.
Details
News Market Reaction – VEEV
The recorded move for VEEV in the trading session of this news was -0.46%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Deep application provides foundation for commercial execution
The Vault CRM solution will support Merck as they enter one of the most significant launch periods in the company's history across a diverse set of new therapeutic areas and modalities.
"We are excited to expand our strategic partnership with Veeva by moving to Vault CRM," said Dave Williams, executive vice president and chief information and digital officer at Merck. "We share a deep commitment to customer success, and Vault CRM will provide Merck the technology foundation to drive commercial execution."
"Merck has consistently been at the forefront of leading-edge science that improves the lives of millions around the world," said Veeva CEO Peter Gassner. "We are honored to be a strategic partner to Merck and it is great to see our partnership extend to Vault CRM."
Vault CRM is part of the Vault CRM Suite of deep applications that drive more effective commercial execution across personal and digital channels. With advanced global capabilities, Vault CRM Suite addresses the industry's unique regional and country-specific business and compliance requirements.
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Contact:
| |
Maria Scurry | Meera Lakhani-Patel |
View original content to download multimedia:https://www.prnewswire.com/news-releases/merck-commits-to-veeva-vault-crm-302509227.html
SOURCE Veeva Systems
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.